Vanja de Weerd

2.2k citations
44 papers · 1.4k · h-index 17

Impact in

  • Cancer Research top 2%
    • Cancer-related molecular mechanisms research
    • MicroRNA in disease regulation
    • Cancer Genomics and Diagnostics
  • Oncology top 10%
    • Cancer Cells and Metastasis

Papers in

  • Cancer Research 35
    • Cancer Genomics and Diagnostics 21
    • Cancer-related molecular mechanisms research 8
    • MicroRNA in disease regulation 5
    • Breast Cancer Treatment Studies 5
  • Molecular Biology 18
    • Circular RNAs in diseases 5
Co-authors
John W.M. Martens (41 shared papers)Anieta M. Sieuwerts (27 shared papers)John A. Foekens (21 shared papers)Marcel Smid (17 shared papers)Maxime P. Look (8 shared papers)Jan G.M. Klijn (4 shared papers)Antonius W.M. Boersma (1 shared paper)Erik A.C. Wiemer (1 shared paper)
Journals
Molecular Oncology (7 papers)Breast Cancer Research and Treatment (4 papers)Oncotarget (3 papers)Cancer Research (3 papers)Scientific Reports (2 papers)
Partner nations
NetherlandsSpainUnited States

In The Last Decade

Vanja de Weerd

42 papers receiving 1.4k citations

Peers

Vanja de Weerd
Comparison fields: 5 of 86
  • Cancer Research 890
  • Oncology 401
  • Molecular Biology 892
  • Pulmonary and Respiratory Medicine 182
  • Pathology and Forensic Medicine 94
Replace David C. Corney with:
David C. Corney United States
Nathalie Meyer‐Schaller Switzerland
Kalpana Ramnarayanan Singapore
Kaitlyn A. Webster United States
R Montoya France
Natalie Meyer Canada
Alice H. Berger United States
Oddmund Nordgård Norway
Daniel Klevebring Sweden
Yannick Saintigny France
Vanja de Weerd relative to David C. Corney United States David C. Corney's profile →
Citations per field
00.5×1.5×2.0×
David C. Corney · 1×
Citations per year

Countries citing papers authored by Vanja de Weerd

Since Specialization
Citations

This map shows the geographic impact of Vanja de Weerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanja de Weerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanja de Weerd more than expected).

Fields of papers citing papers by Vanja de Weerd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanja de Weerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanja de Weerd. The network helps show where Vanja de Weerd may publish in the future.

Co-authors

The 25 scholars most cited alongside Vanja de Weerd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vanja de Weerd Line = papers co-authored together Vanja de Weerd links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
Proceedings of the National Academy of Sciences ·John A. Foekens, Anieta M. Sieuwerts, Marcel Smid, Maxime P. Look, Vanja de Weerd, Antonius W.M. Boersma, Jan G.M. Klijn, Erik A.C. Wiemer, John W.M. Martens
2008304
2
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
Oncotarget ·Roxana S. Redis, Anieta M. Sieuwerts, Maxime P. Look, Oana Tudoran, Cristina Ivan, Riccardo Spizzo, Xinna Zhang, Vanja de Weerd, Masayoshi Shimizu, Hui Ling, Rareş Buiga, Victor I. Pop, Alexandru Irimie, Riccardo Fodde, I. Bedrosian, John W.M. Martens, John A. Foekens, Ioana Berindan‐Neagoe, George A. Călin
2013156
3
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer
Breast Cancer Research and Treatment ·F. Germán Rodríguez-González, Anieta M. Sieuwerts, Marcel Smid, Maxime P. Look, Marion E. Meijer‐van Gelder, Vanja de Weerd, Stefan Sleijfer, John W.M. Martens, John A. Foekens
2010116
4
Gene length corrected trimmed mean of M-values (GeTMM) processing of RNA-seq data performs similarly in intersample analyses while improving intrasample comparisons
BMC Bioinformatics ·(unknown), Marcel Smid, Robert R.J. Coebergh van den Braak, Harmen J.G. van de Werken, Job van Riet, Anne van Galen, Vanja de Weerd, Michelle van der Vlugt‐Daane, Sandra I. Bril, Zarina S. Lalmahomed, Wigard P. Kloosterman, Saskia M. Wilting, John A. Foekens, Jan N.M. IJzermans, John W.M. Martens, Anieta M. Sieuwerts
2018115
5
KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue
International Journal of Cancer ·Bianca Mostert, Yuqiu Jiang, Anieta M. Sieuwerts, Haiying Wang, Joan Bolt‐de Vries, Katharina Biermann, Jaco Kraan, Zarina S. Lalmahomed, Anne van Galen, Vanja de Weerd, Petra van der Spoel, Raquel Ramírez‐Moreno, Cornelis Verhoef, Jan N.M. IJzermans, Yixin Wang, Jan‐Willem Gratama, John A. Foekens, Stefan Sleijfer, John W.M. Martens
2012110
6
Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients
Clinical Cancer Research ·Anieta M. Sieuwerts, Maxime P. Look, Marion E. Meijer‐van Gelder, Mieke Timmermans, Anita M.A.C. Trapman, Roberto Rodríguez García, Miranda Arnold, Anneke J.W. Goedheer, Vanja de Weerd, Henk Portengen, Jan G.M. Klijn, John A. Foekens
200674
7
T lymphocytes facilitate brain metastasis of breast cancer by inducing Guanylate-Binding Protein 1 expression
Acta Neuropathologica ·Dana A. M. Mustafa, Rute M. S. M. Pedrosa, Marcel Smid, Marcel van der Weiden, Vanja de Weerd, Alex L. Nigg, Cor Berrevoets, Lona Zeneyedpour, Neibla Priego, Manuel Valiente, Theo M. Luider, Reno Debets, John W.M. Martens, John A. Foekens, Anieta M. Sieuwerts, Johan M. Kros
201867
8
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
Breast Cancer Research and Treatment ·Muhammad Riaz, Els M.J.J. Berns, Anieta M. Sieuwerts, Kirsten Ruigrok-Ritstier, Vanja de Weerd, Arwin Groenewoud, André G. Uitterlinden, Maxime P. Look, Jan G.M. Klijn, Stefan Sleijfer, John A. Foekens, John W.M. Martens
201146
9
mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients
Molecular Oncology ·Bianca Mostert, Anieta M. Sieuwerts, Joan Bolt‐de Vries, Jaco Kraan, Zarina S. Lalmahomed, Anne van Galen, Petra van der Spoel, Vanja de Weerd, Raquel Ramírez‐Moreno, Marcel Smid, Cornelis Verhoef, Jan N.M. IJzermans, Jan W. Gratama, Stefan Sleijfer, John A. Foekens, John W.M. Martens
201539
10
Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer
Oncotarget ·Wendy Onstenk, Anieta M. Sieuwerts, Bianca Mostert, Zarina S. Lalmahomed, Joan Bolt‐de Vries, Anne van Galen, Marcel Smid, Jaco Kraan, Mai N. Van, Vanja de Weerd, Raquel Ramírez‐Moreno, Katharina Biermann, Cornelis Verhoef, Dirk J. Grünhagen, Jan N.M. IJzermans, Jan W. Gratama, John W.M. Martens, John A. Foekens, Stefan Sleijfer
201634
11
Association of microRNA-7 and its binding partner CDR1-AS with the prognosis and prediction of 1st-line tamoxifen therapy in breast cancer
Scientific Reports ·Katharina Uhr, Anieta M. Sieuwerts, Vanja de Weerd, Marcel Smid, Dora Hammerl, John A. Foekens, John W.M. Martens
201833
12
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
Breast Cancer Research and Treatment ·Jord H.A. Nagel, Justine Peeters, Marcel Smid, Anieta M. Sieuwerts, Marijke Wasielewski, Vanja de Weerd, Anita Trapman-Jansen, Ans van den Ouweland, Hennie T. Brüggenwirth, Wilfred F. J. van IJcken, Jan G.M. Klijn, Peter J. van der Spek, John A. Foekens, John W.M. Martens, Mieke Schutte, Hanne Meijers‐Heijboer
201128
13
Progressive APOBEC3B mRNA expression in distant breast cancer metastases
PLoS ONE ·Anieta M. Sieuwerts, Willemijne A.M.E. Schrijver, Simone U. Dalm, Vanja de Weerd, Cathy B. Moelans, Natalie D. ter Hoeve, P. J. van Diest, John W.M. Martens, Carolien H. M. van Deurzen
201727
14
Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer
American Journal Of Pathology ·Shusma C. Doebar, Anieta M. Sieuwerts, Vanja de Weerd, Hans Stoop, John W.M. Martens, Carolien H. M. van Deurzen
201725
15
Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases
Clinical Cancer Research ·Lindsay Angus, Teoman Deger, Agnes Jager, John W.M. Martens, Vanja de Weerd, Irene van Heuvel, Martin J. van den Bent, Peter A.E. Sillevis Smitt, Johan M. Kros, Eric M. Bindels, Ellen Heitzer, Stefan Sleijfer, Joost L.M. Jongen, Saskia M. Wilting
202122
16
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments
Clinical Epigenetics ·Teoman Deger, Ruben Boers, Vanja de Weerd, Lindsay Angus, Marjolijn M. J. van der Put, Joachim Boers, Zakia Azmani, Wilfred F. J. van IJcken, Dirk J. Grünhagen, Lisanne F. van Dessel, Martijn P. Lolkema, Cornelis Verhoef, Stefan Sleijfer, John W.M. Martens, Joost Gribnau, Saskia M. Wilting
202117
17
Integrative Analysis of Genomics and Proteomics Data on Clinical Breast Cancer Tissue Specimens Extracted with Acid Guanidinium Thiocyanate–Phenol–Chloroform
Journal of Proteome Research ·René B. H. Braakman, Karel Bezstarosti, Anieta M. Sieuwerts, Vanja de Weerd, Anne M. van Galen, Christoph Stingl, Theo M. Luider, Mieke Timmermans, Marcel Smid, John W.M. Martens, John A. Foekens, Jeroen Demmers, Arzu Umar
201517
18
Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer
Molecular Oncology ·Pauline A.J. Mendelaar, Debbie Robbrecht, Maud Rijnders, Ronald de Wit, Vanja de Weerd, Teoman Deger, Hans M. Westgeest, Maureen J.B. Aarts, Jens Voortman, John W.M. Martens, Astrid A.M. van der Veldt, J. Alberto Nakauma-González, Saskia M. Wilting, Martijn P. Lolkema
202214
19
Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study
Breast Cancer Research ·Anieta M. Sieuwerts, Marleen Ansems, Maxime P. Look, Paul N. Span, Vanja de Weerd, Anne van Galen, John A. Foekens, Gosse J. Adema, John W.M. Martens
201013
20
Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting
Molecular Oncology ·Anieta M. Sieuwerts, Maria Lyng, Marion E. Meijer‐van Gelder, Vanja de Weerd, Fred C.G.J. Sweep, John A. Foekens, Paul N. Span, John W.M. Martens, Henrik J. Ditzel
201413

About Vanja de Weerd

Vanja de Weerd is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 44 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (21 papers), Cancer-related molecular mechanisms research (8 papers), Genetic factors in colorectal cancer (7 papers), Cancer Cells and Metastasis (6 papers), MicroRNA in disease regulation (5 papers), Breast Cancer Treatment Studies (5 papers), Circular RNAs in diseases (5 papers) and Estrogen and related hormone effects (5 papers). The work is most often cited by research in Cancer Research (890 citations), Oncology (401 citations), Molecular Biology (892 citations), Pulmonary and Respiratory Medicine (182 citations) and Pathology and Forensic Medicine (94 citations). Vanja de Weerd has collaborated with scholars based in Netherlands, Spain and United States. Frequent co-authors include John W.M. Martens, Anieta M. Sieuwerts, John A. Foekens, Marcel Smid, Maxime P. Look, Jan G.M. Klijn, Antonius W.M. Boersma, Erik A.C. Wiemer, Stefan Sleijfer and Marion E. Meijer‐van Gelder. Their work appears in journals such as Molecular Oncology, Breast Cancer Research and Treatment, Oncotarget, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. CorneyBreakdown of academic impact, for papers by Nathalie Meyer‐SchallerBreakdown of academic impact, for papers by Kalpana RamnarayananBreakdown of academic impact, for papers by Kaitlyn A. WebsterBreakdown of academic impact, for papers by R MontoyaBreakdown of academic impact, for papers by Natalie MeyerBreakdown of academic impact, for papers by Alice H. BergerBreakdown of academic impact, for papers by Oddmund NordgårdBreakdown of academic impact, for papers by Daniel KlevebringBreakdown of academic impact, for papers by Yannick Saintigny